Catalog / single peptides / Tesamorelin
Lyophilized Sterile Vial Tested: 99.5%
Tesamorelin (GHRH Analogue)
Current Lot: MV-2026-TES10-01
High-Purity Lyophilized Peptide

Tesamorelin (GHRH Analogue)

10mg / 5mL Lyophilized HPLC Purity: 99.5% Target: ≥ 99.0%

Tesamorelin is a synthetic growth hormone-releasing factor analog composed of the 44 amino acids of human GHRH with an N-terminal trans-3-hexenoic acid modification.

Wholesale Commercial Pricing
Verified Provider Portal Required
• No consumer checkout • Tiered volume schedules • Certificate included with shipment
Formula C221H366N72O67S
Molecular Weight 5135.86 g/mol
CAS Registry # 218949-48-5
Peptide Sequence / Structure trans-hexenoyl-GHRH (1-44) amide
Current Lot Verification

Lot #MV-2026-TES10-01 Analytical Results

Independent laboratory testing panel for active distribution batch.

Historical Lot Archive →
Analysis Category Reported Result Analytical Method Verification Status
Purity (RP-HPLC) 99.5% RP-HPLC C18 Conforms
Identity (LC-MS) 5136.0 Da Electrospray MS Conforms
Net Content 10.1 mg Quantitative AAA Conforms
Endotoxin < 0.05 EU/mg USP <85> Conforms

Biological Mechanism of Action

Binds to GHRH receptors to stimulate synthesis and pulsatile release of endogenous GH, thereby increasing circulating IGF-1 concentrations.

Research Focus Areas: GHRH Super-Analogue Lipolysis & Visceral Adiposity IGF-1 Axis

Scientific Literature Cross-Reference

Explore primary peer-reviewed papers, PubMed indexes, and pharmacology data for Tesamorelin.